Since PI3K/Akt/mTOR pathway inhibition is reported to decrease invasion and migration of ovarian carcinoma cell lines [25,26], thus PPL siRNA potentially decreased cellular attachment, migration or movement at least partly via the PI3K/Akt axis. This evidence concerns the gene AKT1 and ovarian carcinoma.